Article
Gene Therapy for Hemophilia.
Molecular therapy : the journal of the American Society of Gene Therapy - 3 May 2017
Nienhuis Arthur W, Nathwani Amit C, Davidoff Andrew M
Abstract excerpt
The X-linked bleeding disorder hemophilia causes frequent and exaggerated bleeding that can be life-threatening if untreated. Conventional therapy requires frequent intravenous infusions of the missing coagulation protein (factor VIII [FVIII] for hemophilia A and factor IX [FIX] for hemophilia B). However, a lasting cure through gene therapy has long been sought. After a series of successes in small and large...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
